Français
ItalianoBond Merck & Co 5.15% ( US58933YBN40 ) in USD
| Issuer | Merck & Co | ||||||
| Market price |  100.00 % ⇌ |
||||||
| Country |  United States
|
||||||
| ISIN code |
 US58933YBN40 ( in USD )
|
||||||
| Interest rate | 5.15% per year ( payment 2 times a year) | ||||||
| Maturity | 17/05/2063 | ||||||
|
Prospectus brochure in PDF format |
|||||||
| Minimal amount | / | ||||||
| Total amount | / | ||||||
| Cusip | 58933YBN4 | ||||||
| Standard & Poor's ( S&P ) rating | A+ ( Upper medium grade - Investment-grade ) | ||||||
| Moody's rating | Aa3 ( High grade - Investment-grade ) | ||||||
| Next Coupon | 17/11/2026 ( In 91 days ) | ||||||
| Detailed description |
Merck & Co., Inc. is a leading global biopharmaceutical company that discovers, develops, manufactures, and markets a broad range of innovative health solutions across various therapeutic areas. The Bond issued by Merck & Co ( United States ) , in USD, with the ISIN code US58933YBN40, pays a coupon of 5.15% per year. The coupons are paid 2 times per year and the Bond maturity is 17/05/2063 The Bond issued by Merck & Co ( United States ) , in USD, with the ISIN code US58933YBN40, was rated Aa3 ( High grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Merck & Co ( United States ) , in USD, with the ISIN code US58933YBN40, was rated A+ ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||
| |||||||